Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 01/16/2026 | PUT | $150.00 | 1,175 | +841 | +251.80% |
| 01/16/2026 | CALL | $195.00 | 2,211 | +574 | +35.06% |
| 12/19/2025 | PUT | $165.00 | 1,036 | +287 | +38.32% |
| 04/17/2026 | CALL | $200.00 | 3,154 | +201 | +6.81% |
| 04/17/2026 | PUT | $200.00 | 213 | +200 | +1,538.46% |
| 01/16/2026 | CALL | $175.00 | 1,205 | +180 | +17.56% |
| 01/16/2026 | PUT | $160.00 | 575 | -323 | -35.97% |
| 02/20/2026 | CALL | $220.00 | 546 | -352 | -39.20% |
| 12/19/2025 | PUT | $190.00 | 97 | -380 | -79.66% |
| 12/19/2025 | PUT | $185.00 | 750 | -434 | -36.66% |
| 01/16/2026 | CALL | $240.00 | 1,431 | -1,042 | -42.14% |
| 01/16/2026 | CALL | $165.00 | 4,369 | -1,657 | -27.50% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Price (T.Rowe) New Horizons Fund | 3.08% | 4.2M | 85.34M |
| Vanguard Total Stock Market Index Fund | 3.02% | 4.11M | 83.55M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.72% | 3.71M | 75.31M |
| Vanguard Small-Cap Index Fund | 2.56% | 3.49M | 70.91M |
| iShares Russell 2000 ETF | 2.18% | 2.98M | 60.48M |
| Price (T.Rowe) Health Sciences Fund | 1.76% | 2.41M | 48.87M |
| Delaware Group Equity Fds V-Small Cap Core Fund | 1.67% | 2.27M | 46.14M |
| Price (T.Rowe) Small Cap Stock Fund | 1.59% | 2.17M | 44.02M |
| Vanguard Small-Cap Growth Index Fund | 1.48% | 2.02M | 40.97M |
| Price (T.Rowe) Small-Cap Value Fund | 1.44% | 1.97M | 40.04M |
Annual Changes to the Nasdaq-100 Index®
12/12 09:00 pm
GlobeNewswire Inc.
Read more30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks
11/30 04:14 am
The Motley Fool
Read moreDPP1 Inhibitor Market Set to Reach New Heights in the Coming Decade | DelveInsight
09/08 01:00 pm
GlobeNewswire Inc.
Read moreNon-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight
08/25 03:00 pm
GlobeNewswire Inc.
Read morePulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight
08/14 01:00 pm
GlobeNewswire Inc.
Read moreRussell Rebalance: 3 Stocks Ready to Move Higher
06/20 01:37 pm
Investing.com
Read moreInsmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price Forecast
06/11 01:32 pm
Benzinga
Read more8MM Bronchiectasis Market Opportunity Assessment and Forecasts, 2033 - Pipeline Innovations Expected to Add $1.8 Billion in Bronchiectasis Market Sales
05/23 04:49 am
GlobeNewswire Inc.
Read moreBronchiectasis Market to Show Positive Growth at a CAGR of 13.7% by 2034 | DelveInsight
01/21 02:00 pm
GlobeNewswire Inc.
Read moreEvolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight
01/14 02:00 pm
GlobeNewswire Inc.
Read moreA Russell 2000 Bull Market Could Be Coming: 1 Spectacular BlackRock ETF to Buy Hand Over Fist Before It Gets Here
01/12 05:48 am
The Motley Fool
Read moreGroundbreaking Insights Unveiled in Non-Cystic Fibrosis Bronchiectasis Pipeline Report
11/28 11:57 am
GlobeNewswire Inc.
Read moreHigh Levels of Cooperation, Care Drive Employees to Give Extra at the Best Small and Medium Workplaces
08/28 07:00 am
GlobeNewswire Inc.
Read moreInsmed Unusual Options Activity For July 11 - Benzinga
07/11 01:48 pm
Benzinga
Read moreWall Street Breakfast: The Week Ahead
06/30 09:10 am
Seeking Alpha
Read moreWall Street Breakfast: The Week Ahead
06/23 06:52 am
Seeking Alpha
Read moreInsmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
05/29 12:20 pm
Zacks Investment Research
Read moreInsmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
05/10 11:14 am
Zacks Investment Research
Read moreInsmed (INSM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
05/09 10:00 am
Zacks Investment Research
Read moreInsmed (INSM) Reports Q1 Loss, Lags Revenue Estimates
05/09 08:15 am
Zacks Investment Research
Read moreShould You Buy Insmed (INSM) Ahead of Earnings?
05/08 10:19 am
Zacks Investment Research
Read moreWill Tango Therapeutics, Inc. (TNGX) Report Negative Q1 Earnings? What You Should Know
05/07 10:00 am
Zacks Investment Research
Read moreInsmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
05/02 10:01 am
Zacks Investment Research
Read moreInsmed (INSM) Reports Q4 Loss, Misses Revenue Estimates
02/22 09:10 am
Zacks Investment Research
Read moreInsmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
02/15 11:00 am
Zacks Investment Research
Read moreWhere Insmed Stands With Analysts
11/20 01:00 pm
Benzinga
Read moreAmgen (AMGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
10/24 10:00 am
Zacks Investment Research
Read moreWill Insmed (INSM) Report Negative Earnings Next Week? What You Should Know
10/19 10:02 am
Zacks Investment Research
Read moreWhere Insmed Stands With Analysts
09/06 11:00 am
Benzinga
Read moreInsmed (INSM) Up on Positive Data From MAC Lung Disease Study
09/06 07:46 am
Zacks Investment Research
Read moreWhy America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
09/05 01:34 pm
Benzinga
Read moreWhy Insmed Stock Is Soaring Today
09/05 11:52 am
The Motley Fool
Read moreBrady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday
09/05 10:43 am
Benzinga
Read moreInsmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
08/03 09:05 am
Zacks Investment Research
Read moreG1 Therapeutics (GTHX) Tops Q2 Earnings and Revenue Estimates
08/02 07:45 am
Zacks Investment Research
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 26, 2023
07/26 11:00 am
Benzinga
Read moreInsmed (INSM) Reports Q1 Loss, Tops Revenue Estimates
05/04 08:55 am
Zacks Investment Research
Read moreRevance Therapeutics, Inc. (RVNC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
05/02 10:01 am
Zacks Investment Research
Read moreInsmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
04/27 10:03 am
Zacks Investment Research
Read moreInsmed (INSM) Reports Q4 Loss, Misses Revenue Estimates
02/23 10:15 am
Zacks Investment Research
Read moreY-mAbs Therapeutics, Inc. (YMAB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
02/16 11:01 am
Zacks Investment Research
Read moreInsmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
02/09 11:01 am
Zacks Investment Research
Read moreWall Street Analysts Believe Insmed (INSM) Could Rally 98.26%: Here's is How to Trade
01/24 10:55 am
Zacks Investment Research
Read moreBarclays Maintains Overweight Rating for Insmed: Here's What You Need To Know
01/20 01:00 pm
Benzinga
Read moreAnalyst Expectations for Insmed's Future
01/20 09:00 am
Benzinga
Read moreCoupa Software, Horizon Therapeutics And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
12/12 07:03 am
Benzinga
Read moreAnalyst Ratings for Insmed
12/07 08:02 am
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
11/18 12:58 pm
Benzinga
Read more